(Q37543923)

English

Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo

scientific article published on 08 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Stephanie M Cohen

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Ridhwi Mukerji

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Shuang Cai

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Ivan Damjanov

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

M Laird Forrest

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Mark S Cohen

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

8 October 2011

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

The American Journal of Surgery

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

202

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

646-52; discussion 652-3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5198781

23 August 2017

Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5198781

23 August 2017

Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5198781

23 August 2017

Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5198781

23 August 2017

Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5198781

23 August 2017

Platinum organ toxicity and possible prevention in patients with testicular cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5198781

23 August 2017

Nanoparticulate alternatives for drug delivery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5198781

6 September 2017

INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5198781

14 September 2017

A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5198781

14 September 2017

Prognosis following local recurrence in the conservatively treated breast cancer patient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5198781

25 June 2018

Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5198781

1 September 2018

Effect of small-sized liposomal Adriamycin administered by various routes on a metastatic breast cancer model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5198781

1 September 2018

Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21982998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/21982998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early-stage breast cancer: arm edema after wide excision and breast irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21982998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin-induced cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21982998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21982998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21982998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute

1 reference

https://pubmed.ncbi.nlm.nih.gov/21982998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.AMJSURG.2011.06.027

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37543923&oldid=2174940906"